Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.
On-demand online seminar:
Advancements in Oral Insulin Development: Are we nearly there yet?
We record all of our free online seminars, so that you have the possibility to watch them on-demand at your convenience. Watch here our seminar titled: "Advancements in Oral Insulin Development: Are we nearly there yet?". In this online seminar, Profil's Executive Project Director Dr. Eric Zijlstra talks about the development of oral insulins. Watch here
Corporate Social Responsibility in Clinical Trials
Corporate social responsibility is important as it encourages businesses to adopt sustainable practices, reduces the environmental impact, and promotes conservation of natural resources. It also helps to mitigate climate change and to protect ecosystems, contributing to the long-term health and well-being of our planet. Javiera Villagra, Senior CRA at Profil, explains, what Profil does to ensure that the company deals with our planet in a responsible manner.
Non-invasive Continuous Glucose Monitoring: A Proof-of-Concept Study
Non-invasive continuous glucose monitoring has the potential to revolutionize diabetes care. It eliminates the need for frequent finger pricks, hence, providing a more comfortable experience for individuals with diabetes. Read our latest publication of a proof-of-concept study perfomed by Profil.
Meet us at upcoming conferences
Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to schedule a meeting and tell you more about our expertise! Upcoming events in 2022:
EASD, October 02 - 06, 2023, Hamburg, Germany
OCT New England, November 01 - 02 2023, Boston, MA, USA
Bio Europe, November 06 - 08 2023, Munich, Germany